Sponsor Dossier
Petrus Pharmaceuticals
Sponsor Dossier for Petrus Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: BISACODYL
- Brand: Cal-500
- Brand: Cal-600
- Brand: Cal-600+D
- Brand: Centa-Vite
- Brand: Cranberry
- Brand: Hartley's Gripe Water Oral
- Brand: LITTLE
- Device (sponsor): Lubricant, eye
- Device (sponsor): Lubricant, eye
- Device (sponsor): Lubricant, eye
- Device (sponsor): General-body orifice lubricant, non-sterile
- Device (sponsor): Artificial saliva
- Device (sponsor): General-body orifice lubricant, sterile
- Device (sponsor): Medicine chamber spacer
- Device (sponsor): Lubricant, eye
About
Petrus Pharmaceuticals is an Australian Private Company with ABN 21 108 884 126, registered in Western Australia and currently active. The company has traded under the business names Myadec, Petrus Pharmaceuticals, and Unisom.
Portfolio
Petrus Pharmaceuticals holds 20 brands on the ARTG, with 1 indexable brand and 1 brand with PBS-listed items. The portfolio includes brands such as Bisacodyl, Cal-500, Cal-600, Cal-600+D, Centa-Vite, Cranberry, Hartley's Gripe Water Oral, Little, Mag-Sup, Myadec, Oral-Eze, and Oraplex Cold Sore.
Therapeutic focus
— Complementary Medicine: 15 brands — Musculoskeletal: 2 brands — Gastroenterology: 2 brands — Pain Management: 1 brand
PBS footprint
One brand in the Petrus Pharmaceuticals portfolio holds PBS-listed items, with the latest PBS schedule date touched on 1 May 2026.